Navigation Links
Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain
Date:11/26/2012

TEL AVIV, Israel, November 26, 2012 /PRNewswire/ --

Israel-based medical device company  Headway medical  reports the successful completion of a series of clinical trials of Occiflex, its innovative therapeutic table designed to reduce chronic neck pain and headaches. The device will be available, starting in 2013, to physiotherapy clinics and rehabilitation centers throughout the world.

A revolutionary new device based on the principles of physiotherapy, Occiflex supports slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic pain. The Occiflex table mechanism allows physiotherapists to devise a manual mobilization file that is tailored to the needs of each patient, and, since it does not depend on the therapist's physical abilities, it can continue therapy for much longer than is standard and possible today. Plus, since each patient's therapy protocol is saved in a database, treatment can be reproduced precisely each time. The patient's file can be modified at any time, as conditions changes. The Occiflex treatment table improves the condition of the cervical joints, muscle, ligaments, and central nervous system control over the neck and head.

The Clinical Journal of Pain recently published a scientific article that describes the clinical trial conducted by Headway in the physiotherapy department of the Bnei Zion Medical Center in Haifa, Israel. The trial tested the advanced prototype developed by the company. Results indeed demonstrated a reduction of chronic neck pain in the patients and increased mobility.

According to Tamir Levital, CEO of Headway, "Occiflex will make the work of 50,000 physiotherapy and pain centers around the world more efficient and provide relief for the hundreds of millions who suffer from chronic neck pain and headaches. It will also save physiotherapists time and energy, and permit them to treat a number of patients simultaneously. The results of our trials show that Occiflex permits more precise, effective, repeated, and longer treatment than is possible today. We are very happy with the results of the trial and are getting ready to market Occiflex starting in 2013."

Headway, which got its start in the Misgav Venture Accelerator (owned by the Trendlines Group), was founded in 2006 by Dr. Yaron River, chief physician at the Neurology Department, Hillel Yaffe Medical Center, Hadera. The company has raised $1.5 million from private investors, the Misgav Venture Accelerator, and government R&D grants.

Media relations:
Efrat Kaduri
Ofir Shpigel Media and Public Relations
+972-4-9535030


'/>"/>
SOURCE Headway Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujifilm Spotlights DR Expansion, Innovation At RSNA 2012
2. Jury for 2012 Intercultural Innovation Award Announced
3. Le Dr Beau Lotto se joint aux grands penseurs à loccasion du débat sur linnovation 2012
4. Le professeur Brian Cox se joint aux grands penseurs à loccasion du débat sur linnovation 2012
5. Cutting-Edge German Medical Innovations Put Patients First
6. El profesor Brian Cox se une a los grandes pensadores en The Innovation Debate 2012
7. El doctor Beau Lotto se une a los grandes pensadores en The Innovation Debate 2012
8. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
9. CardioMEMS Named as a Finalist for Intel Innovation Award
10. Innovations in Ophthalmic Devices - Anterior Segment
11. Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
Breaking Medicine News(10 mins):